Bulletin
Investor Alert

New York Markets Close in:

Market Snapshot Winners and Losers

Cardiff Oncology Inc.

NAS: CRDF

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
Cardiff Oncology Inc.

Market open

CRDF
/zigman2/quotes/201555650/composite

$

1.18

Change

-0.06 -4.84%

Volume

Volume 312,770

May 24, 2022, 2:51 p.m.

Real time quotes

/zigman2/quotes/201555650/composite

Previous close

$ 1.24

$ 1.18

Change

-0.06 -4.84%

Day low

Day high

$1.16

$1.24

Open
Open: 1.22

52 week low

52 week high

$1.13

$8.58

Open

Market cap

$53.70M

Average volume

646,084

P/E ratio

N/A

Rev. per Employee

$15,696

EPS

-0.84

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/crdf

MarketWatch News on CRDF

  1. Cardiff Oncology stock price target cut to $9 from $14 at Maxim Group

    8:35 a.m. Feb. 25, 2022

    - Tomi Kilgore

  2. Cardiff Oncology stock price target cut to $14 from $25 at Maxim Group

    8:47 a.m. Jan. 24, 2022

    - Tomi Kilgore

  3. Cardiff Oncology stock price target raised to $25 from $20 at Maxim Group

    11:36 a.m. Sept. 9, 2021

    - Tomi Kilgore

  4. Cancer Meeting’s High Hopes for Amgen and Gilead

    8:22 a.m. Sept. 21, 2020

    - Barron's Online

  5. TrovaGene shares downgraded to a hold rating from buy at Maxim Group

    8:42 a.m. Nov. 10, 2017

    - Trey Williams

  6. TrovaGene upgraded to buy from hold at Maxim Group

    2:06 p.m. April 12, 2017

    - Tomi Kilgore

  7. David Sokol Sizes Up Middleburg Financial

    12:05 a.m. April 9, 2016

    - Barron's Online

  8. TrovaGene stock price target cut to $8 from $11 at Janney Montgomery Scott

    9:41 a.m. March 11, 2016

    - Tomi Kilgore

  9. TrovaGene downgraded to neutral from buy at Janney Montgomery Scott

    9:41 a.m. March 11, 2016

    - Tomi Kilgore

Analyst Ratings

/news/nonmarketwatch/company/us/crdf

Other News on CRDF

  1. Cardiff Oncology: Risky Investment

    10:09 a.m. May 19, 2022

    - Seeking Alpha

  3. 10-Q: CARDIFF ONCOLOGY, INC.

    4:03 p.m. May 5, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  4. Guardant Health: Leaping Growth With Epic

    11:15 a.m. April 14, 2022

    - Seeking Alpha

  5. Cardiff Oncology announces departure of medical chief

    4:29 p.m. April 12, 2022

    - Seeking Alpha

  6. Cardiff Oncology (CRDF) Investor Presentation - Slideshow

    2:43 p.m. March 31, 2022

    - Seeking Alpha

  9. 10-K: CARDIFF ONCOLOGY, INC.

    5:03 p.m. Feb. 24, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  12. Cardiff Oncology (CRDF) - Investor Presentation slideshow

    1:35 p.m. Jan. 31, 2022

    - Seeking Alpha

  16. CLFD, NURO and PIXY among mid-day movers

    1:38 p.m. Jan. 19, 2022

    - Seeking Alpha

  17. These 2 Nasdaq Stocks Are Poised to Make Big Moves Today

    10:02 a.m. Jan. 19, 2022

    - Motley Fool

  20. My 3 Top Biopharma Stock Picks for 2022

    11:30 a.m. Jan. 9, 2022

    - Motley Fool

  21. Loading more headlines...
/news/pressrelease/company/us/crdf

Press Releases on CRDF

  4. Monday Sector Laggards: Drugs, Biotechnology Stocks

    12:09 p.m. April 18, 2022

    - MarketNewsVideo.com

  5. Monday Sector Laggards: Drugs, Biotechnology Stocks

    12:02 p.m. April 18, 2022

    - MarketNewsVideo.com

  6. Cardiff Oncology Announces Departure of Chief Medical Officer

    4:00 p.m. April 12, 2022

    - PR Newswire - PRF

  21. Loading more headlines...

Rates »

Mortgage Equity Savings Auto
Link to MarketWatch's Slice.